Illumina to Acquire GRAIL Read More
Deciphering the Role of Long Non-Coding RNA in Cancer

Customer Interview

Deciphering the Role of Long Non-Coding RNA in Cancer

Researchers are using RNA-Seq to reveal how lncRNAs could be used to identify, measure, and treat cancer.

Read Article
The Changing Landscape of NGS Implementation in Molecular Diagnostic...

Customer Interview

The Changing Landscape of NGS Implementation in Molecular Diagnostic...

Key opinion leaders discuss the ongoing challenges and potential of NGS in oncology testing.

Read Article
Munich Leukemia Laboratory: Utilizing NGS for new insights into...

Customer Videos

Munich Leukemia Laboratory: Utilizing NGS for new insights into...

Dr Torsten Haferlach of Munich Leukemia Laboratory (MLL) discusses their goal to sequence, by whole genome sequencing, 5,000 patients with...

View Video
 

Core Technology

Sequencing

See what sequencing can do for you

Learn MoreCompare Sequencers
 

Core Technology

Microarrays

Analyze genetic variation on any scale

Learn MoreCompare Array Scanners
 

COVIDSeq Test Expands to More Customers

FDA amendment leverages the power of various Illumina sequencers for COVID-19 testing

Read Article

Innovations in Library Prep

We keep you on the forefront of emerging applications through continued innovation. Fast, simple library prep and enrichment workflow from Illumina

Learn More

Announcing the NovaSeq 6000 v1.5 Reagent Kit

Unlocking deeper discoveries with the $600 genome

See Details

Training and Webinars

Illumina offers webinars and free online training courses to get the most out of your experiments and products

View WebinarsView Courses

Featured News

Illumina Pledges US $20 Million in Sequencing Tech for Africa

Joins Africa CDC alongside the Bill & Melinda Gates Foundation and others in a four-year plan

Read Article
 
Employee Story

A day in the life of territory account manager Jakob Nielsen

View Video View More Stories